Seminars in Hematology
Volume 45 , Pages S11-S16 , July 2008

Targeted Treatment and New Agents in Diffuse Large B-Cell Lymphoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: John P. Leonard, Research support/Principal Investigator: Biogen Idec, Cephalon, Genentech, GSK, Immunetics, Millennium, Seattle Genetics; Consultant/Scientific Advisory Board: Berlex, Biogen Idec, Bristol Myers, Cougar Biotechnology, Genentech, GSK, Millennium, Wyeth; Speaker's Bureau: Biogen Idec, Genentech, GSK, Millennium.

PII: S0037-1963(08)00120-0

doi: 10.1053/j.seminhematol.2008.07.004

Seminars in Hematology
Volume 45 , Pages S11-S16 , July 2008

Article Tools

* Image Usage & Resolution